Market Cap 82.94M
Revenue (ttm) 0.00
Net Income (ttm) -23.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,427,400
Avg Vol 153,700
Day's Range N/A - N/A
Shares Out 59.24M
Stochastic %K 60%
Beta 2.99
Analysts Strong Sell
Price Target $4.00

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management i...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 506 8462
Address:
1350 South Loop Road, Alameda, United States
66Harry
66Harry Aug. 6 at 3:31 AM
$VANI I am surprise Vani didn't go much higher, game changer in medical field.
0 · Reply
WDfinance
WDfinance Aug. 5 at 11:27 PM
$VANI Has the topline in human data for npm-115 been released yet ?
0 · Reply
Raxothus
Raxothus Aug. 5 at 7:36 PM
EOD CONTINUATION WATCHLIST - 08/05/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $SWIN - 9.8x volume, 6.6% VWAP stretch, micro float. Strong afternoon push with sustained strength. Watching for gap and continuation over 4.68+. $ATLX - 2.4x volume, 5.2% VWAP stretch, small float. Held VWAP into Power Hour. Needs breakout over 6.47+ to extend. $IMMX - 2.6x volume, 3.1% VWAP stretch, small float. Late day strength above VWAP. Watching for clean open over 2.92+. $VANI - 6.3x volume, 11.0% VWAP stretch, small float. Big volume and strong VWAP hold. Needs gap over 1.55+ to confirm continuation. $NB - 3.1x volume, 6.1% VWAP stretch, medium float. Solid grind all day. Needs clean push through 3.75+ for follow-through. 📌 Watching for gap and VWAP continuation only. Focus on volume + structure. No random holds. #EOD #VWAP #Momentum #SmallCaps #DayTrading #ContinuationSetups
1 · Reply
Iamparishilton
Iamparishilton Aug. 5 at 5:45 PM
$VANI Let’s go
0 · Reply
Stocksprofessional
Stocksprofessional Aug. 5 at 5:33 PM
$VANI 📈
0 · Reply
Niconiconee
Niconiconee Aug. 5 at 5:30 PM
$VANI lf new 52w high
0 · Reply
ZabDad
ZabDad Aug. 5 at 5:02 PM
0 · Reply
bullseye86
bullseye86 Aug. 5 at 3:28 PM
$VANI love the potential here
0 · Reply
prismmarketview
prismmarketview Aug. 5 at 3:11 PM
NASDAQ: $VANI Vivani Medical shifts focus to its NPM-139 semaglutide implant after preclinical data showed ~20% weight loss from a single dose lasting over 6 months, aiming to offer a long-acting alternative for chronic weight management. https://prismmarketview.com/vivani-medical-prioritizes-development-of-npm-139-semaglutide-implant-after-positive-preclinical-weight-loss-data/
1 · Reply
Iamparishilton
Iamparishilton Aug. 5 at 2:57 PM
$VANI let’s go
0 · Reply
Latest News on VANI
Vivani Medical to Present at TIDES Conference 2024

May 9, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical to Present at TIDES Conference 2024


Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 29, 2024, 7:25 AM EST - 1 year ago

Vivani Medical (VANI) stock price surged: is it a good buy?


Vivani Medical to Present at BIO Investor Forum

Oct 16, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical to Present at BIO Investor Forum


Vivani Medical to Present at the Boulder Peptide Symposium

Sep 7, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the Boulder Peptide Symposium


Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

Aug 31, 2022, 6:00 AM EDT - 3 years ago

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)


66Harry
66Harry Aug. 6 at 3:31 AM
$VANI I am surprise Vani didn't go much higher, game changer in medical field.
0 · Reply
WDfinance
WDfinance Aug. 5 at 11:27 PM
$VANI Has the topline in human data for npm-115 been released yet ?
0 · Reply
Raxothus
Raxothus Aug. 5 at 7:36 PM
EOD CONTINUATION WATCHLIST - 08/05/25 Focused on stocks that held VWAP and pushed into Power Hour with strength $SWIN - 9.8x volume, 6.6% VWAP stretch, micro float. Strong afternoon push with sustained strength. Watching for gap and continuation over 4.68+. $ATLX - 2.4x volume, 5.2% VWAP stretch, small float. Held VWAP into Power Hour. Needs breakout over 6.47+ to extend. $IMMX - 2.6x volume, 3.1% VWAP stretch, small float. Late day strength above VWAP. Watching for clean open over 2.92+. $VANI - 6.3x volume, 11.0% VWAP stretch, small float. Big volume and strong VWAP hold. Needs gap over 1.55+ to confirm continuation. $NB - 3.1x volume, 6.1% VWAP stretch, medium float. Solid grind all day. Needs clean push through 3.75+ for follow-through. 📌 Watching for gap and VWAP continuation only. Focus on volume + structure. No random holds. #EOD #VWAP #Momentum #SmallCaps #DayTrading #ContinuationSetups
1 · Reply
Iamparishilton
Iamparishilton Aug. 5 at 5:45 PM
$VANI Let’s go
0 · Reply
Stocksprofessional
Stocksprofessional Aug. 5 at 5:33 PM
$VANI 📈
0 · Reply
Niconiconee
Niconiconee Aug. 5 at 5:30 PM
$VANI lf new 52w high
0 · Reply
ZabDad
ZabDad Aug. 5 at 5:02 PM
0 · Reply
bullseye86
bullseye86 Aug. 5 at 3:28 PM
$VANI love the potential here
0 · Reply
prismmarketview
prismmarketview Aug. 5 at 3:11 PM
NASDAQ: $VANI Vivani Medical shifts focus to its NPM-139 semaglutide implant after preclinical data showed ~20% weight loss from a single dose lasting over 6 months, aiming to offer a long-acting alternative for chronic weight management. https://prismmarketview.com/vivani-medical-prioritizes-development-of-npm-139-semaglutide-implant-after-positive-preclinical-weight-loss-data/
1 · Reply
Iamparishilton
Iamparishilton Aug. 5 at 2:57 PM
$VANI let’s go
0 · Reply
Stocksprofessional
Stocksprofessional Aug. 5 at 2:31 PM
$VANI I was initially hesitant to go all in, but after seeing Vivani’s impressive and robust results, I’m now fully committed—officially all in. The strength of their technology is becoming increasingly clear, not just in the treatment of obesity, but across a wide range of chronic conditions. This isn’t a one-off breakthrough—it’s a versatile platform with the potential to redefine how we tackle some of the most persistent health challenges. Vivani’s nano drug-delivery system shows tremendous promise not only in addressing obesity, but also in managing type 2 diabetes, cardiovascular diseases, and neurological disorders—areas where precision and consistent drug delivery are critical. But the potential goes far beyond that.
1 · Reply
Iamparishilton
Iamparishilton Aug. 5 at 2:03 PM
$VANI let’s run momma
0 · Reply
BC322032
BC322032 Aug. 5 at 1:57 PM
$VANI - Expect close near $3 today with positive trial news!
1 · Reply
Niconiconee
Niconiconee Aug. 5 at 1:55 PM
$VANI https://investors.vivani.com/investors/news-events/press-releases/detail/198/vivani-medical-announces-rapid-advancement-of-npm-139-a Rapid advancement
0 · Reply
Niconiconee
Niconiconee Aug. 5 at 1:52 PM
$VANI heck yes, more news?!
0 · Reply
Stocksprofessional
Stocksprofessional Aug. 5 at 1:50 PM
$VANI up we go 📈
0 · Reply
Stocksprofessional
Stocksprofessional Aug. 5 at 1:24 PM
$VANI This pullback is shaking out the weak hands — the fearful miss the gains while the big players prepare for the next leg up.
1 · Reply
Stocksprofessional
Stocksprofessional Aug. 5 at 1:09 PM
1 · Reply
BC322032
BC322032 Aug. 5 at 1:07 PM
$VANI BOOM! Positive results and ready for next stage! Time for BLAST OFF! https://investors.vivani.com/investors/news-events/press-releases/detail/198/vivani-medical-announces-rapid-advancement-of-npm-139-a
0 · Reply
Earl40
Earl40 Aug. 5 at 12:35 PM
$VANI Somethings will never change it's just the way it is. When will you ever learn? A pop then back to red on news LMAO
0 · Reply
onlyfactshere
onlyfactshere Aug. 5 at 12:21 PM
$VANI Getting in a starter here at $1.33 Sell later today or in the week Sell at your own comfort levels Good luck to all
0 · Reply
MarcoPolo1111
MarcoPolo1111 Aug. 5 at 12:17 PM
$VANI https://investors.vivani.com/investors/news-events/press-releases/detail/198/vivani-medical-announces-rapid-advancement-of-npm-139-a
1 · Reply